Clinical trial
Phase II Study Treatment of High Risk Non-Hodgkin's Lymphomas
NCT00869284 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study Treatment of High Risk Non-Hodgkin's Lymphomas
- Lead sponsor
- French Innovative Leukemia Organisation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 1994
- Completion date
- February 28, 2009
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.